Loading clinical trials...
Loading clinical trials...
A Multicenter Italian and Spanish Observational Registry on Patients Affected by Spontaneous Coronary Artery Dissection (SCAD)
The study will investigate the clinical features, acute management and follow up of patients affected by spontaneous coronary artery dissection
Spontaneous Coronary Artery Dissection is now being increasingly studied as it is getting more and more relevant as a cause of ACS. Its management is currently a matter of debate due to the absence of RCT and even the trigger events related to this kind of infarction are still unclear. Notably, the benefits from the use of the antiplatelet medications that prolong bleeding time for a condition whose primary pathophysiology may be an intramural bleed are under discussion. Hence, the targets pursued by our study may be essentially distinguished in five main points: 1. To assess the characteristics of SCAD patients highlighting the predisposing and precipitating factors related to the acute event 2. To analyze clinical presentation and management of spontaneous coronary dissections in terms of therapeutic approach in the acute phase (conservative therapy vs revascularization) 3. To evaluate the incidence of SCAD recurrence and of major adverse cardiovascular events (MACEs) at follow-up 4. To analyze the impact of a single antiplatelet therapy (SAPT) over the dual one (DAPT) along with the impact of different P2Y12i regimens on acute and long-term prognosis 5. To evaluate impact of different angiographic SCAD type on outcome
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Start Date
January 1, 2009
Primary Completion Date
December 31, 2019
Completion Date
December 31, 2019
Last Updated
June 4, 2020
314
ACTUAL participants
Lead Sponsor
San Luigi Gonzaga Hospital
NCT06323811
NCT06955663
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03607981